Sierra Oncology Inc
NASDAQ:SRRA
Sierra Oncology Inc
Operating Expenses
Sierra Oncology Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sierra Oncology Inc
NASDAQ:SRRA
|
Operating Expenses
-$102.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Operating Expenses
-$214.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Operating Expenses
-$167.4m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Operating Expenses
-$101.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Operating Expenses
-$238.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-40%
|
|
Spectral Medical Inc
TSX:EDT
|
Operating Expenses
-CA$13.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
0%
|
See Also
What is Sierra Oncology Inc's Operating Expenses?
Operating Expenses
-102.6m
USD
Based on the financial report for Mar 31, 2022, Sierra Oncology Inc's Operating Expenses amounts to -102.6m USD.
What is Sierra Oncology Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-16%
Over the last year, the Operating Expenses growth was -49%. The average annual Operating Expenses growth rates for Sierra Oncology Inc have been -22% over the past three years , -16% over the past five years .